Skip to main content

Table 2 Projected uptake rates of epoetin SEB in Canada, years 1 to 5

From: A budget impact analysis of the introduction of erythropoiesis stimulating agent subsequent entry biologics for the treatment of anemia of chronic kidney disease in Canada

Epoetin SEB uptake rates
Year 1 Year 2 Year 3 Year 4 Year 5
1% 4% 7% 11% 14%
  1. SEB = subsequent entry biologic.